Agustin is the Head of the newly created Commercial Innovation team at Shire Pharmaceuticals. His team is responsible for driving innovation across Shire’s commercial products in the areas of operational excellence, advanced analytics and design thinking.Agustin is also a co-founder of SQZ Biotech, a start-up out of MIT. SQZ Biotech is one of FierceBiotech's '2015 Fierce 15' companies and won the first prize in 2014 MassChallenge (out of 1,600+ applicants worldwide). Their technology, CellSqueeze, was selected as one of the ten world changing ideas by Scientific American in 2014. SQZ Biotech recently signed a $500M collaboration with Roche to develop cancer immunotherapies using the CellSqueeze technology. Agustin was SQZ Biotech's CEO and President, successfully completing both seed and series A funding rounds, and growing the company from 1 to 20 employees.